These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 16677002)
1. Solution-phase parallel synthesis of a pyridinium pyrazol-3-olate inner salt library using a three-component reaction. Varga L; Nagy T; Dorman G; Kalman F; Urge L; Darvas F J Comb Chem; 2006; 8(3):338-43. PubMed ID: 16677002 [TBL] [Abstract][Full Text] [Related]
2. Insecticidal lead identification by screening benzopyrano[4,3-c] pyrazol-3(2H)-ones library constructed from multiple-parallel synthesis under microwave irradiation. Zhou ZZ; Yang GF Bioorg Med Chem; 2006 Dec; 14(24):8666-74. PubMed ID: 16949292 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines. Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146 [TBL] [Abstract][Full Text] [Related]
4. Development of a novel, multifunctional, membrane-interactive pyridinium salt with potent anticancer activity. Fahs S; Rowther FB; Dennison SR; Patil-Sen Y; Warr T; Snape TJ Bioorg Med Chem Lett; 2014 Aug; 24(15):3430-3. PubMed ID: 24951329 [TBL] [Abstract][Full Text] [Related]
5. Regioselective synthesis and antitumor screening of some novel N-phenylpyrazole derivatives. Farag AM; Mayhoub AS; Barakat SE; Bayomi AH Bioorg Med Chem; 2008 Jan; 16(2):881-9. PubMed ID: 17962022 [TBL] [Abstract][Full Text] [Related]
6. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists. Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171 [TBL] [Abstract][Full Text] [Related]
7. A novel strategy for the synthesis of 3-(N-heteryl)pyrrole derivatives. Khlebnikov AF; Golovkina MV; Novikov MS; Yufit DS Org Lett; 2012 Jul; 14(14):3768-71. PubMed ID: 22765306 [TBL] [Abstract][Full Text] [Related]
8. A convenient ultrasound-promoted regioselective synthesis of fused polycyclic 4-aryl-3-methyl-4,7-dihydro-1H-pyrazolo[3,4-b]pyridines. Nikpassand M; Mamaghani M; Shirini F; Tabatabaeian K Ultrason Sonochem; 2010 Feb; 17(2):301-5. PubMed ID: 19720550 [TBL] [Abstract][Full Text] [Related]
9. Three-component synthesis and anticancer evaluation of polycyclic indenopyridines lead to the discovery of a novel indenoheterocycle with potent apoptosis inducing properties. Manpadi M; Uglinskii PY; Rastogi SK; Cotter KM; Wong YS; Anderson LA; Ortega AJ; Van Slambrouck S; Steelant WF; Rogelj S; Tongwa P; Antipin MY; Magedov IV; Kornienko A Org Biomol Chem; 2007 Dec; 5(23):3865-72. PubMed ID: 18004468 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of a new series of 3-[3-(substituted phenyl)-1-isonicotinoyl-1H-pyrazol-5-yl]-2H-chromen-2-one derivatives. Aragade P; Maddi V; Khode S; Palkar M; Ronad P; Mamledesai S; Satyanarayana D Arch Pharm (Weinheim); 2009 Jun; 342(6):361-6. PubMed ID: 19475595 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells. Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors. Lin R; Chiu G; Yu Y; Connolly PJ; Li S; Lu Y; Adams M; Fuentes-Pesquera AR; Emanuel SL; Greenberger LM Bioorg Med Chem Lett; 2007 Aug; 17(16):4557-61. PubMed ID: 17574416 [TBL] [Abstract][Full Text] [Related]
13. 4-(4-pyrimidinyl)pyridinium salts. Analogs of the hypoglycemic 4-pyrazolylpyridinium salts. Bauer VJ; Dalalian HP; Safir SR J Med Chem; 1968 Nov; 11(6):1263-4. PubMed ID: 5680064 [No Abstract] [Full Text] [Related]
14. Synthesis of new 4-[2-(4-methyl(amino)sulfonylphenyl)-5-trifluoromethyl-2H-pyrazol-3-yl]-1,2,3,6-tetrahydropyridines: a search for novel nitric oxide donor anti-inflammatory agents. Chowdhury MA; Abdellatif KR; Dong Y; Knaus EE Bioorg Med Chem; 2008 Oct; 16(19):8882-8. PubMed ID: 18789699 [TBL] [Abstract][Full Text] [Related]
15. Efficient approach to 2-hydroxy-2,3-dihydrofuran derivatives and its application for the synthesis of novel 4-(1H-pyrazol-4-yl)pyridazines. Ma JR; Shu WM; Zheng KL; Ni F; Yin GD; Wu AX Org Biomol Chem; 2015 May; 13(17):4976-80. PubMed ID: 25821120 [TBL] [Abstract][Full Text] [Related]
16. Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption. Sanders JM; Song Y; Chan JM; Zhang Y; Jennings S; Kosztowski T; Odeh S; Flessner R; Schwerdtfeger C; Kotsikorou E; Meints GA; Gómez AO; González-Pacanowska D; Raker AM; Wang H; van Beek ER; Papapoulos SE; Morita CT; Oldfield E J Med Chem; 2005 Apr; 48(8):2957-63. PubMed ID: 15828834 [TBL] [Abstract][Full Text] [Related]
17. Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors. Price S; Bordogna W; Bull RJ; Clark DE; Crackett PH; Dyke HJ; Gill M; Harris NV; Gorski J; Lloyd J; Lockey PM; Mullett J; Roach AG; Roussel F; White AB Bioorg Med Chem Lett; 2007 Jan; 17(2):370-5. PubMed ID: 17095213 [TBL] [Abstract][Full Text] [Related]
18. Luminescence properties of three structures built from 3-cyano-4-dicyanomethylene-5-oxo-4,5-dihydro-1H-pyrrol-2-olate and alkaline metals (Na, K and Rb). Tafeenko VA; Gurskiy SI; Baranov AN; Kaisarova TV; Aslanov LA Acta Crystallogr C; 2009 Feb; 65(Pt 2):m52-5. PubMed ID: 19190369 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of zwitterionic salts of pyridinium-Meldrum acid and barbiturate through unique four-component reactions. Wang QF; Hui L; Hou H; Yan CG J Comb Chem; 2010 Mar; 12(2):260-5. PubMed ID: 20092329 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents. Lin R; Connolly PJ; Lu Y; Chiu G; Li S; Yu Y; Huang S; Li X; Emanuel SL; Middleton SA; Gruninger RH; Adams M; Fuentes-Pesquera AR; Greenberger LM Bioorg Med Chem Lett; 2007 Aug; 17(15):4297-302. PubMed ID: 17532631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]